AssayName: high-resolution mass spectrometry-based proteomics  
AssayName: label-free workflow  
AssayName: single-run method  
AcquisitionMethod: top-15 data-dependent mode  
AcquisitionMethod: top-5 data-dependent acquisition method  
Instrument: quadrupole– Orbitrap mass spectrometer  
Instrument: Q Exactive HF  
Instrument: EASYnLC 1200 ultra-high-pressure system  
IonizationType: nano-electrospray ion source  
FragmentationMethod: higher-energy collisional dissociation (HCD)  
CollisionEnergy: normalized collision energy (NCE) of 27%  
PrecursorMassTolerance: 4.5 ppm  
FragmentMassTolerance: 20 ppm  
FlowRateChromatogram: 350 nl per min  
Separation: liquid chromatography–MS  
GradientTime: 100 min  
FractionationMethod: high-pH reversed-phase fractionation  
FractionationMethod: loss-less nano-fractionator  
SampleTreatment: in-StageTip (iST) method  
Temperature: −80 °C  
Sex: male trauma victims  
Age: aged 21–47 years  
NumberOfBiologicalReplicates: three adult hearts  
NumberOfTechnicalReplicates: technical triplicates  
CleavageAgent: Lys-C  
CleavageAgent: trypsin  
Organism: human  
CellType: cardiac fibroblasts (CF)  
CellType: adipose fibroblasts (AF)  
CellType: endothelial cells (ECs)  
CellType: smooth muscle cells (SMCs)  
OrganismPart: aorta (Ao)  
OrganismPart: pulmonary artery (PA)  
OrganismPart: vena cava inferior (IVC)  
OrganismPart: pulmonary vein (PVe)  
OrganismPart: right atrium (RA)  
OrganismPart: left atrium (LA)  
OrganismPart: right ventricle (RV)  
OrganismPart: left ventricle (LV)  
OrganismPart: tricuspid valve (TV)  
OrganismPart: pulmonary valve (PV)  
OrganismPart: aortic valve (AV)  
OrganismPart: mitral valve (MV)  
OrganismPart: ventricular septum (SepV)  
OrganismPart: atrial septum (SepA)  
OrganismPart: left coronary artery (LCA)  
OrganismPart: right coronary artery (RCA)